OCUL icon

Ocular Therapeutix
OCUL

Overview Fund Activity

68 hedge funds and large institutions have $99.9M invested in Ocular Therapeutix in 2019 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 15 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
68
Holders Change
–
Holders Change %
0%
% of All Funds
1.48%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
13
Increased
24
Reduced
15
Closed
11
Calls
$1.23M
Puts
$647K
Net Calls
+$584K
Net Calls Change
+$25K

Top Buyers

1
OM
1
Opaleye Management
Massachusetts
$13M
2
DAM
2
Deltec Asset Management
New York
$6.23M
3
Man Group
3
Man Group
United Kingdom
$9.5M
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$1.3M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$8.24M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$3.03M
2
ECM
2
Endurant Capital Management
California
$0
3
Invesco
3
Invesco
Georgia
$0
4
Jennison Associates
4
Jennison Associates
New York
$0
5
BCM
5
Bridgeway Capital Management
Texas
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
LWCFA
76
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
– -$79K -20,000 Closed
CS
77
Credit Suisse
Switzerland
– -$57K -14,437 Closed
JGGDR
78
JGP Global Gestao de Recursos
Brazil
– -$55K -13,880 Closed
OFW
79
Omnia Family Wealth
Florida
– -$2K -500 Closed
1 2 3
4